Start Date
August 31, 2010
Primary Completion Date
January 31, 2012
Study Completion Date
January 31, 2012
Eltrombopag
75 mg per day with possible dose escalation to 150 mg per day and 300 mg per day
University of Cincinnati, Cincinnati
Collaborators (1)
GlaxoSmithKline
INDUSTRY
University of Cincinnati
OTHER